MedDataX Logo

Multicentric Retrospective Study of Perinatal Mortality

NCT ID: NCT05491772

Last Updated: 2022-08-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

468 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-08-05

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Background: Perinatal mortality ranges mortality from 22 gestational weeks up to the first 7 days of life and extended mortality goes up to 28 days of life. The perinatal mortality rate is the most sensitive index of the health status of women and their offspring and of the quality of maternal and child health services. Per our knowledge, there is no study that evaluates perinatal mortality in Catalonia, although household data are available from each hospital. Moreover, the official records usually do not match with the household surveys due to lack of clarity on the definitions. Aim: the aim of the study is to compare the WHO perinatal mortality classification following the ICD-PM in comparison with the used classification. Methodology: Multicentric retrospective study. Data from Sant Joan de Déu, Maternitat Clinic and Parc Taulí hospitals.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study of the Short-term Mortality and Morbidity of Newborns Born at a Gestational Age <32 Weeks of Amenorrhea

NCT05150301

Premature Birth
UNKNOWN

Antenatal Detection of Fetal Growth Restriction and Stillbirths Rate.

NCT01995968

Stillbirth Intrauterine Growth Retardation Infant, Small for Gestational Age
UNKNOWN

Predictive Score for Neonatal Mortality for Women With Premature Rupture of Membranes Between 22 and 28 Weeks of Gestation

NCT03108404

Perinatal Mortality Premature Rupture of Fetal Membranes
UNKNOWN

Prognosis of Extremely Premature Birth

NCT01150396

Infant, Premature, Diseases Perinatal Morbidity Development +1 more
UNKNOWN

RPL: Interval to Live Birth and Adverse Perinatal Outcomes

NCT04360564

Abortion, Spontaneous Abortion, Habitual Birth Intervals +2 more
UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Perinatal Morbidity Morbidity;Perinatal Stillbirth ICD

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* stillbirths more than 22 weeks of gestation
* neonatal deaths up to 28 days of life

Exclusion Criteria

\- avortions more than 22 weeks of gestation
Minimum Eligible Age

0 Days

Maximum Eligible Age

28 Days

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospital Sant Joan de Deu

OTHER

Sponsor Role collaborator

Hospital Clínic Sede Maternitat

OTHER

Sponsor Role collaborator

Corporacion Parc Tauli

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nuria Torre-Monmany

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CorporacionPT

Sabadell, Barcelona, Spain

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Spain

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Nuria Torre, MD

Role: CONTACT

[email protected]
937231010 ext. 29312

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Nuria Torre, MD

Role: primary

[email protected]
937231010

References

Explore related publications, articles, or registry entries linked to this study.

Torre Monmany N, Astete JA, Ramaiah D, Suchitra J, Krauel X, Fillol M, Balasubbaiah Y, Alarcon A, Bassat Q. Extended Perinatal Mortality Audit in a Rural Hospital in India. Am J Perinatol. 2023 Mar;40(4):375-386. doi: 10.1055/s-0041-1727220. Epub 2021 Apr 26.

Reference Type BACKGROUND
PMID: 33902133 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Perinatal mortality - pHD NTM

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Venous Thromboembolism in Pregnancy Study
NCT00856076 UNKNOWN
sFlt1/PlGF and Planned Delivery to Prevent Preeclampsia at Term.
NCT04766866 RECRUITING NA
Impact of First-trimester Preeclampsia Screening on Perinatal and Maternal Morbidity (RANSPRE)
NCT05521776 RECRUITING NA
Maternal-fetal Outcomes of Genital Blood Loss Beyond 18 Weeks of Pregnancy
NCT06802874 RECRUITING
Molecular Study of the Maternal-fetal Interface in Preeclampsia.
NCT06232668 RECRUITING
First-trimester Prediction of Preeclampsia
NCT02189148 COMPLETED
Biological Markers of Disease in the Prediction of Preterm Delivery, Preeclampsia and Intra-Uterine Growth Retardation: A Longtitudinal Study
NCT00340899 COMPLETED
Procalcitonin and Threatened Premature Delivery
NCT01977079 TERMINATED NA
Mothers Working to Prevent Early Stillbirth Study 20-28
NCT06005272 RECRUITING
Prediction of Preeclampsia by Comprehensive Markers.
NCT03665623 COMPLETED
Angiogenic Factors in the Conservative Management of Gestational Hypertension
NCT06123377 RECRUITING NA
Antenatal Allopurinol During Fetal Hypoxia
NCT00189007 UNKNOWN PHASE3
Non-invasive Placental Chromosome Exploration of Intrauterine Growth Restriction
NCT05023161 RECRUITING
Low Weight Heparin prOphylaxis for Placental-Mediated Complications of PrEgnancy
NCT01388322 COMPLETED PHASE3
THROmbinography in Pregnant Woman and in Vitro Action of Low Molecular Weight HEparin
NCT06575309 RECRUITING
Observational Study in UTERO - Placental 3D Doppler Examination: Interest for Pre-eclampsia Screening During Pregnancy
NCT00930397 COMPLETED
Prediction of Preeclampsia and Other Pregnancy Complications Following Combined Iterative Screening
NCT03067298 COMPLETED
Women's Perspective on First-trimester Preeclampsia Screening
NCT05123560 UNKNOWN
Routine Ultrasound Screening in the Third Trimester
NCT01594463 COMPLETED NA
Consequences of Antiangiogenic Factors Involved in Preeclampsia on Intra-uterine Growth Restricted Preterm Newborn
NCT01648855 COMPLETED
Serum Markers in Preeclamptic Women
NCT01361737 COMPLETED
New Biomarkers Associated With the Risk of Premature Delivery.
NCT04067908 COMPLETED NA
Congenital Malformations and Maternal Use of Anti-hypertensive Medication in the United Kingdom
NCT02459990 COMPLETED
Safety of Direct Oral Anticoagulant During Pregnancy
NCT06179823 COMPLETED
Hypertension Explored in Long-term Postpartum Follow-up in Later Life
NCT06187012 RECRUITING